BRCA1 and lung adenocarcinoma: Previous studies show that low BRCA1 expression is correlated with poor outcome in LUSC patients but, in contrast, is associated with a better response to platinum-based chemotherapy in lung adenocarcinoma (LUAD) patients [58,59].